<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT201104106163N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2011-06-05</date_registration>
      <primary_sponsor>University Malaya</primary_sponsor>
      <public_title>A community-based healthy lifestyle intervention amongst high risk adults to prevent type 2 diabetes in Malaysia (Co-HELP)- a translational research</public_title>
      <acronym>Co-HELP</acronym>
      <scientific_title>A community-based healthy lifestyle intervention amongst high risk adults to prevent type 2 diabetes in Malaysia (Co-HELP)- a translational research</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2011-09-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>328</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/6600</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention.</study_design>
      <phase>1</phase>
      <hc_freetext>type 2 diabetes.</hc_freetext>
      <i_freetext>Intervention 1: A) Lifestyle modification intervention group&#13;
The lifestyle modification intervention sessions will be conducted in group format, coordinated and facilitated by the peer educators. The intervention will focuses on empowerment of participants to change their lifestyle. This intervention will incorporates diet, physical activity and healthy behaviour modification. The contact schedule occurs in three phases, with an early 3- month intensive phase ( 1 group session every 2 weeks) followed by a 6-month non-intensive phase ( 1 group session every month) and a 3-month maintenance phase. The goals set for this intervention is based on what is outlined in the Clinical Practice Guidelines by Ministry of Health Malaysia, Management of type 2 Diabetes Mellitus, 4th edition 2009 to produce modest but yet achievable outcomes as below:&#13;
•	Reduction of 5-10% of initial body weight for all overweight and obese participants&#13;
•	Reduction of calorie intake (20-25 kcal/kg body weight)&#13;
•	Increase light to moderate physical activity to at least 150 minutes/ week&#13;
&#13;
The group will have series of different sessions with professionals like Physicians, Dietician/ Nutritionist and Physical trainer specialist during the intensive phase. Throughout the intervention, the participants will have a continuous support from Diabetic Educators (Nurses) and Peer Educators that acts as program facilitators. Facilitators will consult the professional health providers if any problems arise during the intervention sessions. Participants will also be referred to relevant health providers if the problem could not be handled by the program facilitators.&#13;
&#13;
i)	0 to 3rd month: Intensive intervention -2 weekly sessions for 3 months. Total 6 sessions, deliver by Professionals (Doctor, Nurse, Dietician, Sport Medicine Physician, Diabetic Educator or Community Health Nurse&#13;
ii)	4th to 6 month: Non-intensive intervention-1 monthly sessions for 3 months. Total 3 sessions, deliver by Peer Educators with supervision by professionals.&#13;
iii)	7th to 9th month: Non-intensive intervention- 1 monthly sessions for 3 months. Total 3 sessions, deliver by Peer Educators with supervision by professionals&#13;
iv)	10th to 12th month: Maintenance of intervention- Follow up of participants by peer educators via phone, e-mail  or home visits&#13;
&#13;
•	Session with physician: To increase knowledge of the participants about the disease, sign and symptoms, common risk factors and complications associated with the disease.&#13;
&#13;
•	Session with dietician or nutritionist: Not only focusing on food pyramid but also on healthy food choice. Might also conduct practical session on how to prepare healthy meals.&#13;
&#13;
•	Session with sport medicine physician or physical trainer: Encourage participants to do light to moderate exercises at the beginning but later will encourage them to do moderate to high intensity exercises. The prescription is according to the participant’s age and health status.&#13;
&#13;
•	Session with Diabetes Educators and Peer Educators: The session with Diabetes Educators and Peer Educators will be conducted on monthly basis with intention to ensure all participants are able to continue lifestyle modification activities that have been taught earlier. On the other hand this will also benefits the participating MDA’s members to continue and sustain the activities at their organization even after the study is over.&#13;
&#13;
The activities will be conducted in big group and small groups. For example; if the activity is in the form of one and half hour lecture, the participants will be grouped in large group of 50 people. But if the activities involve group-work or discussion, they will be grouped in smaller group of 10 to 15 people. Intervention 2: B) Conventional intervention group : &#13;
Participants in the conventional intervention group will receive general verbal and written information about diet and exercise during baseline investigation and subsequent blood taking visits.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Norliza binti Ibrahim</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Lembah Pantai</address>
        <city>Kuala Lumpur</city>
        <country1>Malaysia</country1>
        <zip>59100</zip>
        <telephone>60-0379676657</telephone>
        <email>drliza@siswa.um.edu.my</email>
        <affiliation>Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Moy Foong Ming</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Lembah Pantai</address>
        <city>Kuala Lumpur</city>
        <country1>Malaysia</country1>
        <zip>59100</zip>
        <telephone>60-0379676657</telephone>
        <email>moyfm@ummc.edu.my</email>
        <affiliation>Department of Social and Preventive Medicine, University of Malaya</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Malaysia</country2>
    </countries>
    <criteria>
      <inclusion_criteria>a)Inclusion criteria : -Adults of high risk groups age between 18 to 65 years old, Malaysian nationality -Able to read and write in Bahasa Malaysia or English language -Willing to give written consent and participate voluntarily has Impaired fasting glucose (IFG) between 5.6 to 6.9 mmol/L (100-125 mg/dL) and /or Impaired Glucose Tolerance (IGT) between 7.8 to 11.0 mmol/L (140-199 mg/dL) -Overweight (BMI&gt; 23 kg/m²) with other risk factors like Waist Circumference (WC) &gt; 80 cm in women and &gt; 90 cm in men, history of diabetes in family members, presence of hypertension or dyslipidemia or physically inactive b)Exclusion criteria: -Not willing to give written consent and participate voluntarily or not interested to continue follow up -Has been diagnosed with Diabetes Mellitus -Has fasting plasma glucose ≥7.0 mmol/L(≥126 mg/dL). They will be referred immediately to the health care provider for confirmation of established Diabetes Mellitus during the screening process. -Has been diagnosed with other pre-existing co-morbidities that are contraindicated to adopt light to moderate physical activity (e.g; a recent cardiovascular event including myocardial infarction, angina, stroke, TIA, peripheral vascular disease, congestive heart failure, carotid and coronary vascularizations, severe chronic obstructive pulmonary disease, advanced arthritis, poorly controlled hypertension , any form of cancers that limit lifespan to less than 3 years and require treatment) -Pregnant, psychological disorder or physically disabled which can interfere with participation.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E11.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Non-insulin dependent Diabetes Mellittus without complications</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>A) Lifestyle modification intervention group&#13;
The lifestyle modification intervention sessions will be conducted in group format, coordinated and facilitated by the peer educators. The intervention will focuses on empowerment of participants to change their lifestyle. This intervention will incorporates diet, physical activity and healthy behaviour modification. The contact schedule occurs in three phases, with an early 3- month intensive phase ( 1 group session every 2 weeks) followed by a 6-month non-intensive phase ( 1 group session every month) and a 3-month maintenance phase. The goals set for this intervention is based on what is outlined in the Clinical Practice Guidelines by Ministry of Health Malaysia, Management of type 2 Diabetes Mellitus, 4th edition 2009 to produce modest but yet achievable outcomes as below:&#13;
•	Reduction of 5-10% of initial body weight for all overweight and obese participants&#13;
•	Reduction of calorie intake (20-25 kcal/kg body weight)&#13;
•	Increase light to moderate physical activity to at least 150 minutes/ week&#13;
&#13;
The group will have series of different sessions with professionals like Physicians, Dietician/ Nutritionist and Physical trainer specialist during the intensive phase. Throughout the intervention, the participants will have a continuous support from Diabetic Educators (Nurses) and Peer Educators that acts as program facilitators. Facilitators will consult the professional health providers if any problems arise during the intervention sessions. Participants will also be referred to relevant health providers if the problem could not be handled by the program facilitators.&#13;
&#13;
i)	0 to 3rd month: Intensive intervention -2 weekly sessions for 3 months. Total 6 sessions, deliver by Professionals (Doctor, Nurse, Dietician, Sport Medicine Physician, Diabetic Educator or Community Health Nurse&#13;
ii)	4th to 6 month: Non-intensive intervention-1 monthly sessions for 3 months. Total 3 sessions, deliver by Peer Educators with supervision by professionals.&#13;
iii)	7th to 9th month: Non-intensive intervention- 1 monthly sessions for 3 months. Total 3 sessions, deliver by Peer Educators with supervision by professionals&#13;
iv)	10th to 12th month: Maintenance of intervention- Follow up of participants by peer educators via phone, e-mail  or home visits&#13;
&#13;
•	Session with physician: To increase knowledge of the participants about the disease, sign and symptoms, common risk factors and complications associated with the disease.&#13;
&#13;
•	Session with dietician or nutritionist: Not only focusing on food pyramid but also on healthy food choice. Might also conduct practical session on how to prepare healthy meals.&#13;
&#13;
•	Session with sport medicine physician or physical trainer: Encourage participants to do light to moderate exercises at the beginning but later will encourage them to do moderate to high intensity exercises. The prescription is according to the participant’s age and health status.&#13;
&#13;
•	Session with Diabetes Educators and Peer Educators: The session with Diabetes Educators and Peer Educators will be conducted on monthly basis with intention to ensure all participants are able to continue lifestyle modification activities that have been taught earlier. On the other hand this will also benefits the participating MDA’s members to continue and sustain the activities at their organization even after the study is over.&#13;
&#13;
The activities will be conducted in big group and small groups. For example; if the activity is in the form of one and half hour lecture, the participants will be grouped in large group of 50 people. But if the activities involve group-work or discussion, they will be grouped in smaller group of 10 to 15 people.</i_keyword>
      <i_keyword>B) Conventional intervention group : &#13;
Participants in the conventional intervention group will receive general verbal and written information about diet and exercise during baseline investigation and subsequent blood taking visits.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Changes in blood glucose. Timepoint: Baseline,3 months, 6 months, 9 months,12 months. Method of measurement: Fasting bloood glucose (mmol/L), HbA1C (mmol/L).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Changes in weight. Timepoint: Baseline, 3 months, 6 months, 9 months , 12 months. Method of measurement: Weight (kg).</sec_outcome>
      <sec_outcome>Changes in BMI. Timepoint: baseline, 3rd, 6th, 9th and 12th mth. Method of measurement: BMI (kg/m2).</sec_outcome>
      <sec_outcome>Changes in waist circumference. Timepoint: baseline, 3rd, 6th, 9th and 12th mth. Method of measurement: Waist circumference (cm).</sec_outcome>
      <sec_outcome>Changes in total cholesterol. Timepoint: baseline, 3rd, 6th, 9th and 12 mth. Method of measurement: Total cholesterol (mmol/L).</sec_outcome>
      <sec_outcome>Changes in HDL. Timepoint: baseline, 3rd, 6th, 9th and 12th mth. Method of measurement: HDL (mmol/L).</sec_outcome>
      <sec_outcome>Changes in Triglycerides. Timepoint: baseline, 3rd, 6th, 9th and 12th mth. Method of measurement: TG (mmol/L).</sec_outcome>
      <sec_outcome>Changes in Blood pressure. Timepoint: baseline, 3rd, 6th, 9th and 12th mth. Method of measurement: BP (mm Hg).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id>A community-based healthy lifestyle intervention amongst high risk adults to prevent type 2 diabetes</sec_id>
        <issuing_authority>Iranian Registry of Clinical Trials (IRCT)</issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>University Malaya</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2011-03-18</approval_date>
        <contact_name>University Malaya Medical Centre (UMMC) Medical Ethics Committee</contact_name>
        <contact_address>UMMC, Lembah Pantai Kuala Lumpur Wilayah Persekutuan Kuala Lumpur Malaysia</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
